Autologous Mandril-Based Vascular Grafts
It is well-known that the number of patients requiring a vascular graft for use as arterial bypass or as vascular access site for hemodialysis is ever increasing. The development of tissue-engineered vascular grafts (TEVGs) is a promising method to meet this increasing demand, without having to rely synthetic grafts such as polytetrafluoroethylene (PTFE) or Dacron, that have limited long-term durability. The generation of in vivo TEVGs involves utilizing the host reaction to an implanted biomaterial for the generation of completely autologous tissues. Essentially this approach to the development of TEVGs makes use of the foreign body response to biomaterials for the construction of the entire vascular replacement tissue within the patient’s own body. In this review we will discuss the method of developing in vivo TEVGs and debate the approaches of several research groups that have implemented this method.
This review is partly based on a previous publication in the Journal of Cardiovascular Translational Research (2017, 10(2):167–179) and includes an update with recent literature.
Conflicts of Interest
The authors have no conflicts of interest to disclose.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Bezhaeva T et al (2018) Contribution of bone marrow-derived cells to in situ engineered tissue capsules in a rat model of chronic kidney disease. Biomaterials 194:47–56. https://doi.org/10.1016/j.biomaterials.2018.12.014CrossRefGoogle Scholar
- Brouty-Boye D, Pottin-Clemenceau C, Doucet C, Jasmin C, Azzarone B (2000) Chemokines and CD40 expression in human fibroblasts. Eur J Immunol 30:914–919. https://doi.org/10.1002/1521-4141(200003)30:3<914::aid-immu914>3.0.co;2-dCrossRefGoogle Scholar
- Duffield JS, Lupher M, Thannickal VJ, Wynn TA (2013) Host responses in tissue repair and fibrosis. Annu Rev Pathol Mech Dis 8:241–276. https://doi.org/10.1146/annurev-pathol-020712-163930CrossRefGoogle Scholar
- Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25:5681–5703. https://doi.org/10.1016/j.biomaterials.2004.01.023CrossRefGoogle Scholar
- Guidoin R et al (1984) The Sparks-Mandril arterial prosthesis. An ingenious concept, a total failure. What can we learn from it? J Mal Vasc 9:277–283Google Scholar
- Hallin RW (1975) Complications with the mandril-grown (Sparks) dacron arterial graft. Am Surg 41:550–554Google Scholar
- Kumar G, Waters MS, Farooque TM, Young MF, Simon CG Jr (2012) Freeform fabricated scaffolds with roughened struts that enhance both stem cell proliferation and differentiation by controlling cell shape. Biomaterials 33:4022–4030. https://doi.org/10.1016/j.biomaterials.2012.02.048CrossRefGoogle Scholar
- McGuigan AP, Sefton MV (2007) The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 28:2547–2571. https://doi.org/10.1016/j.biomaterials.2007.01.039CrossRefGoogle Scholar
- Nakayama Y, Furukoshi M, Terazawa T, Iwai R (2018) Development of long in vivo tissue-engineered “biotube” vascular grafts. Biomaterials 185:232–239. https://doi.org/10.1016/j.biomaterials.2018.09.032CrossRefGoogle Scholar
- Peirce EC 2nd (1953) Autologous tissue tubes for aortic grafts in dogs. Surgery 33:648–657Google Scholar
- Rothuizen TC et al (2016a) Development and evaluation of in vivo tissue engineered blood vessels in a porcine model. Biomaterials 75:82–90. https://doi.org/10.1016/j.biomaterials.2015.10.023CrossRefGoogle Scholar
- Rotmans JI et al (2005) Hemodialysis access graft failure: time to revisit an unmet clinical need? J Nephrol 18:9–20Google Scholar
- Shen M, Garcia I, Maier RV, Horbett TA (2004) Effects of adsorbed proteins and surface chemistry on foreign body giant cell formation, tumor necrosis factor alpha release and procoagulant activity of monocytes. J Biomed Mater Res A 70:533–541. https://doi.org/10.1002/jbm.a.30069CrossRefGoogle Scholar
- Tatsumi E, Nakayama Y, Okumura N, Kaneko Y (2018) P2664Long-term follow up of first-in-human study in bypass of stenosis av shunt by an autologous in-body-tissue-engineered (biotube) vascular graft. Eur Heart J 39. https://doi.org/10.1093/eurheartj/ehy565.P2664
- Watanabe T, Kanda K, Ishibashi-Ueda H, Yaku H, Nakayama Y (2010) Autologous small-caliber “biotube” vascular grafts with argatroban loading: a histomorphological examination after implantation to rabbits. J Biomed Mater Res B Appl Biomater 92:236–242. https://doi.org/10.1002/jbm.b.31510CrossRefGoogle Scholar